INS and type 2 diabetes mellitus: Insulin resistance (IR), a central feature of obesity-related metabolic dysregulation, manifests as reduced insulin responsiveness in adipose, hepatic, and muscle tissues, ultimately leading to β-cell failure and T2DM onset.